In vivo treatment of rats with unfractionated heparin (UFH) or low molecular weight heparin (LMWH) does not affect experimentally induced colon carcinoma …
SM Smorenburg, R Vink, M te Lintelo… - Clinical & experimental …, 1999 - Springer
Recent randomized trials have suggested that treatment with low molecular weight heparin
(LMWH) improves survival of cancer patients with venous thromboembolism, as compared …
(LMWH) improves survival of cancer patients with venous thromboembolism, as compared …
[引用][C] In vivo treatment of rats with unfractionated heparin (UFH) or low molecular weight heparin (LMWH) does not affect experimentally induced colon carcinoma …
SM Smorenburg, R Vink, M te Lintelo… - Clinical and …, 1999 - elibrary.ru
Recent randomized trials have suggested that treatment with low molecular weight heparin
(LMWH) improves survival of cancer patients with venous thromboembolism, as compared …
(LMWH) improves survival of cancer patients with venous thromboembolism, as compared …
[PDF][PDF] IN VIVO TREATMENT OF RATS WITH UNFRACTIONATED HEPARIN OR LOW MOLECULAR WEIGHT HEPARIN DOES NOT AFFECT EXPERIMENTALLY …
SM Smorenburg, R Vink, M te Lintelo… - CLINICAL & …, 1999 - researchgate.net
Recent randomized trials have suggested that treatment with low molecular weight heparin
(LMWH) improves survival of cancer patients with venous thromboembolism, as compared …
(LMWH) improves survival of cancer patients with venous thromboembolism, as compared …
In vivo treatment of rats with unfractionated heparin (UFH) or low molecular weight heparin (LMWH) does not affect experimentally induced colon carcinoma …
SM Smorenburg, R Vink, M te Lintelo… - Clinical & …, 1999 - search.proquest.com
Recent randomized trials have suggested that treatment with low molecular weight heparin
(LMWH) improves survival of cancer patients with venous thromboembolism, as compared …
(LMWH) improves survival of cancer patients with venous thromboembolism, as compared …
In vivo treatment of rats with unfractionated heparin (UFH) or low molecular weight heparin (LMWH) does not affect experimentally induced colon carcinoma …
SM Smorenburg, R Vink, M te Lintelo… - Clinical & Experimental …, 1999 - infona.pl
Recent randomized trials have suggested that treatment with low molecular weight heparin
(LMWH) improves survival of cancer patients with venous thromboembolism, as compared …
(LMWH) improves survival of cancer patients with venous thromboembolism, as compared …
In vivo treatment of rats with unfractionated heparin (UFH) or low molecular weight heparin (LMWH) does not affect experimentally induced colon carcinoma …
SM Smorenburg, R Vink, M te Lintelo… - Clinical & …, 1999 - europepmc.org
Recent randomized trials have suggested that treatment with low molecular weight heparin
(LMWH) improves survival of cancer patients with venous thromboembolism, as compared …
(LMWH) improves survival of cancer patients with venous thromboembolism, as compared …
In vivo treatment of rats with unfractionated heparin (UFH) or low molecular weight heparin (LMWH) does not affect experimentally induced colon carcinoma …
SM Smorenburg, R Vink, M te Lintelo… - Clinical & …, 1999 - pubmed.ncbi.nlm.nih.gov
Recent randomized trials have suggested that treatment with low molecular weight heparin
(LMWH) improves survival of cancer patients with venous thromboembolism, as compared …
(LMWH) improves survival of cancer patients with venous thromboembolism, as compared …
In vivo treatment of rats with unfractionated heparin (UFH) or low molecular weight heparin (LMWH) does not affect experimentally induced colon carcinoma …
SM Smorenburg, R Vink… - Clinical & …, 1999 - researchinformation.amsterdamumc …
Recent randomized trials have suggested that treatment with low molecular weight heparin
(LMWH) improves survival of cancer patients with venous thromboembolism, as compared …
(LMWH) improves survival of cancer patients with venous thromboembolism, as compared …